Seagen

US FTC seeks additional info on Pfizer's proposed takeover of Seagen

THE US Federal Trade Commission (FTC) has sought additional information and documentary material related to Pfizer’s proposed acquisition of Seagen Inc , Seagen said on Friday (Jul 14).

The deal for Pfizer will add four approved cancer therapies with combined sales of nearly US$2 billion in 2022.

Pfizer signs US$43 billion Seagen deal in cancer drug push

Pfizer on Monday (Mar 13) struck a roughly US$43 billion deal for Seagen to bulk up its cancer treatments portfolio, as the drugmaker braces for a steep fall in Covid-19 product sales and loss of excl...